# Designing adhesive hydrogels for oral diseases treatment

**Authors:** Yufei Peng, Zhisheng Jiang, Shusen Xu, Liming He, Tong Jiang, Yujie Yang, Xiaoyan Xie, Lanjie Lei

PMC · DOI: 10.1016/j.mtbio.2026.102911 · Materials Today Bio · 2026-02-12

## TL;DR

This review explores adhesive hydrogels for treating oral diseases by analyzing their ability to stick in wet environments and deliver drugs effectively.

## Contribution

The paper introduces a structured three-level hierarchy and emphasizes biomechanical crosstalk in hydrogel design for oral drug delivery.

## Key findings

- Adhesive hydrogels can sustain drug release in dynamic oral environments.
- Biomechanical crosstalk between microbial activity and mechanical fatigue affects adhesive longevity.
- Current testing methods lack integration of physical and biological stressors.

## Abstract

Localized drug delivery in the oral cavity is challenging owing to its wet, dynamic, and microbiologically complex nature. Adhesive hydrogels have attracted increasing attention for their ability to adhere under wet conditions, provide sustained drug release, and respond to pathological environments. This review provides a structured perspective by categorizing advancements into a three-level hierarchy encompassing molecular bonding, network reinforcement, and system-level adaptation. Chemical motifs for interfacial stability and responsive designs are systematically evaluated to enhance site-specific compatibility. Unlike previous reports that primarily cataloged material types, this study distinguishes itself through a rigorous quantitative comparison between experimental hydrogels and clinical gold standards across diverse oral pathologies. A primary differentiator is the emphasis on biomechanical crosstalk where microbial enzymatic activity and mechanical fatigue concurrently dictate the longevity of the adhesive interface. Furthermore, the work identifies systemic disconnects in current testing methodologies and advocates for integrated evaluation paradigms that simulate simultaneous physical and biological stressors. By synthesizing these granular insights, this review offers a comprehensive roadmap for achieving stable and efficient therapy in next-generation oral medicine.

Image 1

## Full-text entities

- **Genes:** MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, mucin [NCBI Gene 100508689], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, SPATA2 (spermatogenesis associated 2) [NCBI Gene 9825] {aka PD1, PPP1R145, tamo}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}
- **Diseases:** fatigue (MESH:D005221), CIOM (MESH:D000084202), dental fluorosis (MESH:D009050), carcinogenesis (MESH:D063646), oral cancer (MESH:D009062), Oral diseases (MESH:D009059), bleeding (MESH:D006470), systemic diseases (MESH:D034721), fracture (MESH:D050723), inflammatory pain (MESH:D010146), trauma (MESH:D014947), Disease (MESH:D004194), Inflammatory (MESH:D007249), Periodontitis (MESH:D010518), Oral Ulcers (MESH:D019226), PCP (MESH:D011020), swelling (MESH:D004487), mucosal irritation (MESH:D001523), dysbiosis (MESH:D064806), diabetes (MESH:D003920), malignant tumors (MESH:D009369), pulp injuries (MESH:D003788), oral (MESH:D020820), oral candidiasis (MESH:D002180), PAA (MESH:D011015), mucosal dysplasia (MESH:D052016), HSV-1 (MESH:C536395), herpes labialis (MESH:D006560), infectious (MESH:D003141), OPMDs (MESH:C537245), Oral Fungal and (MESH:D009181), periodontal disease (MESH:D010510), leukoplakia (MESH:D007971), necrosis (MESH:D009336), hypertension (MESH:D006973), oral precancerous lesions (MESH:D011230), oral leukoplakia (MESH:D007972), Viral Infections (MESH:D014777), Caries (MESH:D003731), diabetic oral ulcer (MESH:D017719), cytotoxic (MESH:D064420), oral mucositis (MESH:D013280), mucosal ulcers (MESH:D014456), cardiovascular ailments (MESH:D002318), CP (MESH:D002972), buccal pouch (MESH:D004062), infected (MESH:D007239), root caries (MESH:D017213)
- **Chemicals:** DMBA (MESH:C082386), Catechol (MESH:C034221), 4-NQO (MESH:D015112), fluoride (MESH:D005459), Carbopol 940 (MESH:C006903), Schiff base (MESH:D012545), water (MESH:D014867), metformin (MESH:D008687), PMMA (MESH:D019904), XTGM (MESH:C002563), HEC (MESH:C002283), ACV (MESH:D000212), cholesterol (MESH:D002784), hydroxyl (MESH:D017665), HA (MESH:D006820), isoguanosine (MESH:C008184), chlorhexidine (MESH:D002710), PAM (MESH:C028797), chitosan (MESH:D048271), Alg (MESH:D000464), oxygen (MESH:D010100), peppermint oil (MESH:C015424), metal (MESH:D008670), EGCG (MESH:C045651), cyanoacrylate (MESH:D003487), polyelectrolyte (MESH:D000071228), rapamycin (MESH:D020123), C (MESH:D002244), polymer (MESH:D011108), polyacrylamide (MESH:C016679), ALA (MESH:D000409), ORI (MESH:C011959), fucoidan (MESH:C007789), Vetbond (MESH:D004659), TA (MESH:D013635), carbomer (MESH:C479038), minocycline (MESH:D008911), catechols (MESH:D002396), CMC (MESH:D002266), baicalein (MESH:C006680), triamcinolone acetonide (MESH:D014222), Baicalin (MESH:C038044), ROS (MESH:D017382), CA (MESH:D002118), PNIPAM (MESH:C052970), dopamine (MESH:D004298), hydrogen (MESH:D006859), cellulose (MESH:D002482), AS (MESH:D001151), quinone (MESH:C004532), ACP (MESH:C519480), SA (MESH:D000077145), CHX (-), DN (MESH:C022306), lidocaine (MESH:D008012), PG (MESH:D011748), hydrogen sulfide (MESH:D006862), amine (MESH:D000588), starch (MESH:D013213), hypericin (MESH:C004965)
- **Species:** Zingiber officinale (ginger, species) [taxon 94328], Streptococcus mutans (species) [taxon 1309], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Candida albicans (species) [taxon 5476], Cricetus cricetus (black-bellied hamster, species) [taxon 10034], Mus musculus (house mouse, species) [taxon 10090], Cricetinae (hamsters, subfamily) [taxon 10026], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Myxine glutinosa (Atlantic hagfish, species) [taxon 7769]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955167/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12955167/full.md

## References

274 references — full list in the complete paper: https://tomesphere.com/paper/PMC12955167/full.md

---
Source: https://tomesphere.com/paper/PMC12955167